Elekta Medical Affairs works closely with the medical community in order to better understand and to internally communicate the needs of the patient and of the practitioner. This insight drives research and development and helps to advance radiotherapy and stereotactic neurosurgery.
By becoming trusted scientific partners in international research collaborations, we are committed to secure, efficient data sharing through data registries. These collaborations lead to the discovery of clinical evidence that supports new, safe and effective uses of radiotherapy for the treatment of cancer and neurological disorders.
Feasibility of stereotactic radiotherapy using a 1.5 T MR-linac: Multi-fraction treatment of pelvic lymph node oligometastases.
Radiotherapy and Oncology 2019; 134: 50-54.
Werensteijn-Honingh, A. M., et al.
Reassessing the Role of Radiation Therapy for the Treatment of Lymphoma: Historical Perspective and Opportunities in the Era of Image-Guided and Adaptive Radiation Therapy.
Journal of Oncology Practice. 2019; 15(4): 175-176.
Schultz, C. J.
THIS CONTENT IS FOR SCIENTIFIC AND EDUCATIONAL PURPOSES - NOT FOR SALES OR PROMOTIONAL USAGE
Rakesh Patel, MD, Director of Th e Targeted Radiation Institutes, Silicon Valley, CA, USA
Ate K. Loonstra, MSc, Manager Global Medical Aff airs, Elekta, Veenendaal, The Netherlands
NYU Langone Medical Center
Geetanjali Cancer Center
Firas Mourtada, M.S.E., Ph.D., DABR, FAAPM
Helen F. Graham Cancer Center, Christiana Care Health System, Newark, DE
Associate Professor (Adj.) MD Anderson Cancer Center, Houston, TX
Associate Professor (Adj.) Thomas Jefferson University, Philadelphia, PA
Department of Oncology, Department of Radiation Oncology, University Medical Center Mannheim
Bristol Gamma Knife Centre, University Hospitals Bristol